Cargando…
Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer
Monitoring disease progression through imaging is playing an increasingly important role in the treatment of prostate cancer. Here, we report that primary mouse prostate cancer cell lines stably expressing luciferase and tumor biomarkers can be monitored through bioluminescence imaging along with as...
Autores principales: | Xu, Peng, Xu, Naijin, Guo, Kai, Xu, Abai, Takenaka, Fumiaki, Matsuura, Eiji, Liu, Chunxiao, Kumon, Hiromi, Huang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078072/ https://www.ncbi.nlm.nih.gov/pubmed/27105511 http://dx.doi.org/10.18632/oncotarget.8846 |
Ejemplares similares
-
A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model
por: Guo, Kai, et al.
Publicado: (2015) -
Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma
por: Li, Xiezhao, et al.
Publicado: (2017) -
The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer
por: Xu, Naijin, et al.
Publicado: (2019) -
Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment
por: Lin, Wenfeng, et al.
Publicado: (2021) -
Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity
por: Xu, Naijin, et al.
Publicado: (2020)